AWARD OF R&D DHA PHASE II SBIR TO TECHNOLOGY HOLDING FOR PROJECT TITLED DEVELOPMENT OF HUMAN MONOCLONAL ANT…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT942523C0005
- Contractor
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $1,099,026
- Period of performance
- Feb 27, 2023 – Jul 26, 2025
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- PSC AN12
- Place of performance
- UT
Public award description
AWARD OF R&D DHA PHASE II SBIR TO TECHNOLOGY HOLDING FOR PROJECT TITLED DEVELOPMENT OF HUMAN MONOCLONAL ANTIBODY THERAPEUTIC AGAINST KLEBSIELLA PNEUMONIAE INFECTION
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.